Stocks
Alnylam Pharmaceuticals (ALNY) ROE US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| ROE, % | ? | -61.6% | -84.5% | -145.0% | 714.9% | 199.5% | 151.4% | |
| Changes by years, y/y, % | -3pp | -23pp | -61pp | +860pp | -515pp | |||
Alnylam Pharmaceuticals. ROE, %
Alnylam Pharmaceuticals. ROE, changes, pp
Alnylam Pharmaceuticals (ALNY) ROE US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| ROE, % | ? | 410.8% | 260.6% | 307.4% | 199.5% | 151.4% | 151.4% | |
| Changes by years, y/y, % | +633pp | +818pp | -1 440pp | -515pp | -259pp | |||
| Changes by quarters, q/q, % | -304pp | -150pp | +47pp | -108pp | -48pp | |||
